Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - CAPITAL EXPENDITURES
Capital Expenditures NVO - Novo Nordisk A/S
-38.9 B
LAST VALUE
-129.50%
2 YEAR CAGR
-25.67%
5 YEAR CAGR
-26.72%
10 YEAR CAGR